These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22193644)

  • 21. Lysosome-associated protein transmembrane-4β-35 is a novel independent prognostic factor in small cell lung cancer.
    Qiao M; Hu G
    Tumour Biol; 2015 Sep; 36(10):7493-9. PubMed ID: 25910706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LAPTM4B polymorphisms is associated with ovarian cancer susceptibility and its prognosis.
    Xu Y; Liu Y; Zhou R; Meng F; Gao Y; Yang S; Li X; Yang M; Lou G
    Jpn J Clin Oncol; 2012 May; 42(5):413-9. PubMed ID: 22412199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients.
    Cheng X; Zheng Z; Bu Z; Wu X; Zhang L; Xing X; Wang X; Hu Y; Du H; Li L; Li S; Zhou R; Wen XZ; Ji JF
    PLoS One; 2015; 10(4):e0121559. PubMed ID: 25849595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical impact of circulating LAPTM4B-35 in pancreatic ductal adenocarcinoma.
    Yang Z; Senninger N; Flammang I; Ye Q; Dhayat SA
    J Cancer Res Clin Oncol; 2019 May; 145(5):1165-1178. PubMed ID: 30778748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of LAPTM4B-35 closely correlated with clinicopathological features and post-resectional survival of gallbladder carcinoma.
    Zhou L; He XD; Chen J; Cui QC; Qu Q; Rui JA; Zhao YP
    Eur J Cancer; 2007 Mar; 43(4):809-15. PubMed ID: 17276673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LAPTM4B-35 overexpression is an independent prognostic marker in endometrial carcinoma.
    Meng FL; Yin MZ; Song HT; Yang H; Lou G; Zhou RL
    Int J Gynecol Cancer; 2010 Jul; 20(5):745-50. PubMed ID: 20966643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CDX2 may be a useful marker to distinguish primary ovarian carcinoid from gastrointestinal metastatic carcinoids to the ovary.
    Desouki MM; Lioyd J; Xu H; Cao D; Barner R; Zhao C
    Hum Pathol; 2013 Nov; 44(11):2536-41. PubMed ID: 24029704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LAPTM4B is a novel diagnostic and prognostic marker for lung adenocarcinoma and associated with mutant EGFR.
    Wang L; Meng Y; Zhang QY
    BMC Cancer; 2019 Apr; 19(1):293. PubMed ID: 30940109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p14 expression differences in ovarian benign, borderline and malignant epithelial tumors.
    Cabral VD; Cerski MR; Sa Brito IT; Kliemann LM
    J Ovarian Res; 2016 Oct; 9(1):69. PubMed ID: 27770808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LAPTM4B allele *2 is a marker of poor prognosis for gallbladder carcinoma.
    Zhai G; Yan K; Ji X; Xu W; Yang J; Xiong F; Su J; McNutt MA; Yang H
    PLoS One; 2012; 7(9):e45290. PubMed ID: 22984631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
    Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
    Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of LAPTM4B-35 is a negative prognostic factor in head and neck squamous cell carcinoma.
    Kotowski U; Kadletz L; Schneider S; Oberndorfer F; Schnoell J; Gurnhofer E; Kenner L; Lucas T; Heiduschka G
    Sci Rep; 2019 Dec; 9(1):18866. PubMed ID: 31827181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma.
    Cho D; Park H; Park SH; Kim K; Chung M; Moon W; Kang M; Jang K
    J Ovarian Res; 2015 Feb; 8():2. PubMed ID: 25823848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancer.
    Thériault BL; Pajovic S; Bernardini MQ; Shaw PA; Gallie BL
    Int J Cancer; 2012 Apr; 130(8):1844-54. PubMed ID: 21618518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hsp70 (HSPA1) Lysine Methylation Status as a Potential Prognostic Factor in Metastatic High-Grade Serous Carcinoma.
    Jakobsson ME; Moen A; Davidson B; Falnes PØ
    PLoS One; 2015; 10(10):e0140168. PubMed ID: 26448330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LAPTM4B-35 is a novel prognostic factor for glioblastoma.
    Dong X; Tamura K; Kobayashi D; Ando N; Sumita K; Maehara T
    J Neurooncol; 2017 Apr; 132(2):295-303. PubMed ID: 28097442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Management and prognosis of metastatic ovarian carcinoma from nongenital tract].
    Wu XF; Chen Y
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jun; 40(6):404-6. PubMed ID: 16008893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LAPTM4B allele *2 is a marker of poor prognosis following hepatic tumor resection for hepatocellular carcinoma.
    Yang H; Zhai G; Ji X; Xiong F; Su J; McNutt MA
    PLoS One; 2012; 7(4):e34984. PubMed ID: 22509374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.